In the present study, we investigated the differential expression of ENO1 in human PDAC and adjacent non-cancer tissues, as well as peripheral blood of PDAC patients and healthy controls, to explore its clinicopathological significance, and diagnostic value as tumor marker single or combined with CA19-9. The gene discussed is ENO1; the disease is neoplasm.